Vontobel Holding’s Werewolf Therapeutics HOWL Stock Holding History

Vontobel Holding’s Portfolio HOWL Stock Details HOWL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$55.3K	Buy	+60,000	New	+$38.1K	﹤0.01%	1458
2026 Q1	–	Sell	-60,003	Closed	-$38K	–	1333
2025 Q4	$38K	Buy	60,003 +24,003	+67%	+$29.2K	﹤0.01%	1415
2025 Q3	$70.9K	Sell	36,000 -4,000	-10%	-$5.48K	﹤0.01%	1307
2025 Q2	$43.6K	Buy	40,000 +5,000	+14%	+$5.15K	﹤0.01%	1237
2025 Q1	$34K	Buy	+35,000	New	+$45.8K	﹤0.01%	1075

Other funds holding HOWL

Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return

Vontobel Holding's HOWL Position: Q3 2026 in Review

Vontobel Holding opened a new position in Werewolf Therapeutics (HOWL) in Q3 2026: 60,000 shares worth $55.3K. The stake represents ﹤0.01% of the portfolio and ranks #1458 among its holdings. This is a return to the name: Vontobel Holding previously reported a position in HOWL as recently as Q4 2025.

Vontobel Holding first reported a position in HOWL in Q1 2025 and has held it in 5 quarters since. The position peaked at $70.9K in Q3 2025. 2 funds tracked by Wall St. Rank hold HOWL as of Q3 2026.

Vontobel Holding held 60,000 shares of Werewolf Therapeutics worth $55.3K as of Q3 2026.
Werewolf Therapeutics was a new Vontobel Holding position in Q3 2026.
Werewolf Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1458 holding.
Vontobel Holding first reported a position in Werewolf Therapeutics in Q1 2025 and has held it in 5 quarters since.
Vontobel Holding's Werewolf Therapeutics position peaked at $70.9K in Q3 2025.
2 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.